General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

Third Harmonic Bio ×

Third Harmonic Bio is a clinical stage biotechnology company developing an oral KIT inhibitor therapy for allergic autoimmune disorders.

  • Sector: Life Sciences
  • Headquarters: Cambridge, MA
  • Date Invested: 12/17/2021
  • Visit Website